All lobbying filings

ORGANOGENESIS INC.

Lobbying for ORGANOGENESIS INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $300,000.00 expenses · posted Oct 16, 2025

Official filing document

Bills named in this filing 1

S 2561
Skin Substitute Access and Payment Reform Act of 2025

Lobbying activity 3

Medicare/Medicaid

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill

Health Issues

FDA policy on chronic wound healing products

Manufacturing

Discussion around new company manufacturing facilities located in Smithfield, Rhode Island.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.